Profound survival benefit with concurrent chemotherapy: insights from a Chinese phase III trial in older patients with esophageal cancer

Schweizer C, Fietkau R, Putz F (2022)

Publication Type: Journal article, Editorial

Publication year: 2022

Journal

Strahlentherapie und Onkologie Urban & Vogel

DOI: 10.1007/s00066-022-01921-6

Authors with CRIS profile

Claudia Schweizer Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie Florian Putz Department of Radiation Oncology

How to cite

APA:

Schweizer, C., Fietkau, R., & Putz, F. (2022). Profound survival benefit with concurrent chemotherapy: insights from a Chinese phase III trial in older patients with esophageal cancer. Strahlentherapie und Onkologie. https://doi.org/10.1007/s00066-022-01921-6

MLA:

Schweizer, Claudia, Rainer Fietkau, and Florian Putz. "Profound survival benefit with concurrent chemotherapy: insights from a Chinese phase III trial in older patients with esophageal cancer." Strahlentherapie und Onkologie (2022).

BibTeX: Download